- Home
- REZI vs MLTX Comparison
REZI vs MLTX Comparison
Compare REZI & MLTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REZI
- MLTX
- Stock Information
- Founded
- REZI 2018
- MLTX 2021
- Country
- REZI United States
- MLTX Switzerland
- Employees
- REZI N/A
- MLTX N/A
- Industry
- REZI Wholesale Distributors
- MLTX Biotechnology: Pharmaceutical Preparations
- Sector
- REZI Industrials
- MLTX Health Care
- Exchange
- REZI Nasdaq
- MLTX Nasdaq
- Market Cap
- REZI 3.1B
- MLTX 2.8B
- IPO Year
- REZI N/A
- MLTX N/A
- Fundamental
- Price
- REZI $24.33
- MLTX $55.03
- Analyst Decision
- REZI Hold
- MLTX Strong Buy
- Analyst Count
- REZI 1
- MLTX 7
- Target Price
- REZI $21.00
- MLTX $73.33
- AVG Volume (30 Days)
- REZI 1.0M
- MLTX 473.9K
- Earning Date
- REZI 08-05-2025
- MLTX 08-06-2025
- Dividend Yield
- REZI N/A
- MLTX N/A
- EPS Growth
- REZI N/A
- MLTX N/A
- EPS
- REZI 0.30
- MLTX N/A
- Revenue
- REZI $7,045,000,000.00
- MLTX N/A
- Revenue This Year
- REZI $11.43
- MLTX $103.42
- Revenue Next Year
- REZI $3.45
- MLTX N/A
- P/E Ratio
- REZI $80.53
- MLTX N/A
- Revenue Growth
- REZI 14.02
- MLTX N/A
- 52 Week Low
- REZI $14.18
- MLTX $31.42
- 52 Week High
- REZI $28.28
- MLTX $58.26
- Technical
- Relative Strength Index (RSI)
- REZI 62.99
- MLTX 69.36
- Support Level
- REZI $23.91
- MLTX $52.65
- Resistance Level
- REZI $24.74
- MLTX $57.45
- Average True Range (ATR)
- REZI 0.58
- MLTX 2.16
- MACD
- REZI -0.03
- MLTX 0.41
- Stochastic Oscillator
- REZI 77.35
- MLTX 78.16
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
About MLTX MoonLake Immunotherapeutics
MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.